Glaukos Corp (GKOS)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$112.76

Buy

$113.16

arrow-up$5.485 (+5.09%)

Prices updated at 01 Apr 2026, 17:31 EDT

Prices minimum 15 mins delay

Prices in USD

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.

S&P 500

1.03%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	383m	507m
	289m	283m
	-108m	-200m
	-28.20	-39.33
	-146m	-188m
	-96m	-146m
Sales, General and administrative	261m	332m
Interest expenses	10m	5m
Provision for income taxes	771,000	-5m
Operating expenses	398m	482m
Income before taxes	-146m	-193m
Net income available to common shareholders	-146m	-188m
	-2.77	-3.28
Net interest income	1m	6m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-2.77	-3.28
Free cash flow per share	-1.5913	-0.4868
Book value/share	11.8438	13.3808
Debt equity ratio	0.134822	0.15831

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	450m	475m
Current liabilities	75m	101m
Total capital	767m	656m
Total debt	103m	104m
Total equity	767m	656m
Total non current liabilities	-	-
Loans	-	-
Total assets	975m	893m
Total liabilities	-	-
Cash and cash equivalents	170m	91m
Common stock	56m	58m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	99m	174m
Cash dividends paid	-	-
	-68m	-39m
Investments (gains) losses	48m	-78m
	174m	95m
Net income	-	-
	-61m	-15m
	-6m	-24m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.